StockMarketWire.com - Investment company Braveheart Investment said it had completed the proof of concept for a COVID-19 test that Paraytec was conducting with the University of Sheffield, and would now move on to securing approvals to finetune the test kit.
'Work will now turn toward the acquisition of clinically relevant data, to facilitate optimisation of the functional capabilities of the test, together with a programme of product refinement and development,' the company said.
'Meanwhile, regulatory approval for live virus trials and the acquisition of clinical data is being sought,' it added. At 9:06am: [LON:BRH] Braveheart Investment Group PLC share price was +14.5p at 50.5p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.